Literature DB >> 14382518

Complications of chlorpromazine therapy in 800 mental-hospital patients.

J LOMAS, R H BOARDMAN, M MARKOWE.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy

Mesh:

Substances:

Year:  1955        PMID: 14382518     DOI: 10.1016/s0140-6736(55)90642-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  [Acute intoxication with the phenothiazine derivative chlorpromazine].

Authors:  J WUETSCHKE
Journal:  Arch Toxikol       Date:  1960

2.  Agranulocytosis and severe leucopenia after chlorpromazine hydrochloride.

Authors:  J C ADAMS; K D CORTI; Q J HOBSON
Journal:  Br Med J       Date:  1956-05-12

3.  Treatment of schizophrenia pacatal and chlorpromazine compared.

Authors:  J L LOMAS
Journal:  Br Med J       Date:  1957-07-13

4.  Chlorpromazine as a suicidal agent.

Authors:  A D DOUGLAS; T J BATES
Journal:  Br Med J       Date:  1957-06-29

5.  The occurrence of epileptic fits in leucotomized patients receiving chlorpromazine therapy.

Authors:  D W LIDDELL; N RETTERSTOL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-05       Impact factor: 10.154

6.  Drugs used in the management of epilepsy.

Authors:  H GARLAND
Journal:  Proc R Soc Med       Date:  1957-08

7.  The effect of chlorpromazine on the electroencephalogram of epileptic patients.

Authors:  W FABISCH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-08       Impact factor: 10.154

8.  The current status of the tranquillizing drugs.

Authors:  P L KURTZ
Journal:  Can Med Assoc J       Date:  1958-02-01       Impact factor: 8.262

9.  [Serum protein picture in psychoses before and during pharmacotherapy].

Authors:  H HIPPIUS; K KANIG; H SELBACH
Journal:  Klin Wochenschr       Date:  1958-06-01

10.  Jaundice in relation to chlorpromazine therapy.

Authors:  B ISAACS; J G MACARTHUR; R M TAYLOR
Journal:  Br Med J       Date:  1955-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.